Supplementary Information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
AOD 9604 Dosage and Protocol: What the Research Supports The standard research protocol for AOD 9604 is 300 mcg per day, administered via subcutaneous injection
This high-quality peptide is designed for those committed to achieving peak health and wellness
This compound is often explored for its potential in promoting metabolic resilience and cellular health
Common in obesity and metabolic syndrome
AOD 9604 clinical trials showed a tolerability profile statistically indistinguishable from placebo